Reply to the comment of Brinster et al. “Acquired hemophilia, rheumatoid arthritis, and TNFα antagonists”

Archive ouverte

Gazal, Steven | Sacré, Karim | Allanore, Yannick | Teruel, Maria | Goodall, Alison, H. | Tohma, Shigeto | Alfredsson, Lars | Okada, Yukinori | Xie, Gang | Constantin, Arnaud | Balsa, Alejandro | Kawasaki, Aya | Nicaise, Pascale | Amos, Christopher | Rodríguez-Rodríguez, Luis | Chiocchia, Gilles | Boileau, Catherine | Zhang, Jinyi | Barnetche, Thomas | Gonzalez-Gay, Miguel | Furukawa, Hiroshi | Cantagrel, Alain | Le Loët, Xavier | Sumida, Takayuki | Hurtado-Nedelec, Margarita | Richez, Christophe | Chollet-Martin, Sylvie | Schaeverbeke, Thierry | Combe, Bernard | Khoryati, Liliane | Coustet, Baptiste | El-Benna, Jammel | Siminovitch, Katherine | Plenge, Robert | Padyukov, Leonid | Martin, Javier | Tsuchiya, Naoyuki | Devauchelle-Pensec, Valérie | Gottenberg, Jacques-Eric | Jousse-Joulin, Sandrine | Berthelot, Jean-Marie | Perdriger, Aleth | Hatron, Pierre Yves | Puéchal, Xavier | Le Guern, Véronique | Sibilia, Jean | Chiche, Laurent | Goëb, Vincent | Larroche, Claire | Fauchais, Anne-Laure | Hayem, Gilles | Morel, Jacques | Zarnitsky, Charles | Dubost, Jean Jacques | Dieudé, Philippe | Pers, Jacques Olivier | Cornec, Divi | Seror, Raphaele | Mariette, Xavier | Nowak, Emmanuel | Saraux, Alain | Banse, Christopher | Vittecoq, Olivier | Levesque, Hervé

Edité par CCSD ; Elsevier Masson -

Comment on:- Acquired hemophilia possibly induced by etanercept in a patient with rheumatoid arthritis. [Joint Bone Spine. 2015]- Acquired hemophilia, rheumatoid arthritis, and TNFα antagonists: Comment on the article "Acquired hemophilia possibly induced by etanercept in a patient with rheumatoid arthritis" by Banse et al., Joint Bone Spine 2015;82:200-2. [Joint Bone Spine. 2015]. International audience. Correspondance

Consulter en ligne

Suggestions

Du même auteur

Identification of Secreted Phosphoprotein 1 Gene as a new Rheumatoid Arthritis Susceptibility Gene

Archive ouverte | Gazal, Steven | CCSD

International audience. Objective To evaluate the contribution of the SPP1 rs11439060 and rs9138 polymorphisms, previously reported as autoimmune risk variants, in the RA genetic background according to anti-citrull...

Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?

Archive ouverte | Devauchelle-Pensec, Valérie | CCSD

International audience. The goal of this study was to determine how the choice of the primary endpoint influenced sample size estimates in randomised controlled trials (RCTs) of treatments for primary Sjögren's synd...

Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.

Archive ouverte | Cornec, Divi | CCSD

International audience. To determine which outcome measures detected rituximab efficacy in the Tolerance and Efficacy of Rituximab in Sjögren's Disease (TEARS) trial and to create a composite endpoint for future tri...

Chargement des enrichissements...